Technical Analysis for NMRD - Nemaura Medical Inc.

Grade Last Price % Change Price Change
F 1.58 -4.24% -0.07
NMRD closed down 4.24 percent on Monday, January 30, 2023, on 3.42 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Feb 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -4.24%
Fell Below 200 DMA Bearish -4.24%
Fell Below 50 DMA Bearish -4.24%
Slingshot Bullish Bullish Swing Setup -4.24%
Volume Surge Other -4.24%
Upper Bollinger Band Walk Strength -4.24%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Nemaura Medical Inc. Description

Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Blood Test Endocrine System Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology I Diabetes Ii Diabetes Blood Sugar Level Continuous Glucose Monitor

Is NMRD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.576
52 Week Low 1.5
Average Volume 118,062
200-Day Moving Average 2.34
50-Day Moving Average 1.98
20-Day Moving Average 1.92
10-Day Moving Average 2.05
Average True Range 0.35
RSI 41.52
ADX 23.96
+DI 28.29
-DI 28.81
Chandelier Exit (Long, 3 ATRs) 2.38
Chandelier Exit (Short, 3 ATRs) 2.56
Upper Bollinger Bands 2.59
Lower Bollinger Band 1.26
Percent B (%b) 0.24
BandWidth 69.15
MACD Line 0.03
MACD Signal Line 0.02
MACD Histogram 0.0088
Fundamentals Value
Market Cap 36.2 Million
Num Shares 22.9 Million
EPS -0.02
Price-to-Earnings (P/E) Ratio -65.83
Price-to-Sales 0.00
Price-to-Book 7.91
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.87
Resistance 3 (R3) 1.87 1.79 1.82
Resistance 2 (R2) 1.79 1.71 1.78 1.80
Resistance 1 (R1) 1.68 1.67 1.64 1.68 1.79
Pivot Point 1.60 1.60 1.58 1.59 1.60
Support 1 (S1) 1.49 1.52 1.45 1.48 1.37
Support 2 (S2) 1.41 1.48 1.40 1.36
Support 3 (S3) 1.30 1.41 1.34
Support 4 (S4) 1.29